Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept

PHASE4CompletedINTERVENTIONAL
Enrollment

217

Participants

Timeline

Start Date

June 5, 2013

Primary Completion Date

March 4, 2014

Study Completion Date

March 4, 2014

Conditions
Rheumatoid ArthritisPlaque Psoriasis
Interventions
DRUG

Etanercept via Autoinjector A

Autoinjector A is a hand-held, reusable, electromechanical device used with a single-use disposable cassette preassembled with an etanercept 50-mg prefilled syringe.

DRUG

Etanercept via Autoinjector B

Autoinjector B is a single-use, spring-loaded, self-contained autoinjector preassembled with an etanercept 50-mg prefilled syringe.

Trial Locations (37)

14127

Research Site, Orchard Park

16635

Research Site, Duncansville

19610

Research Site, Wyomissing

21702

Research Site, Frederick

26301

Research Site, Clarksburg

29414

Research Site, Charleston

33614

Research Site, Tampa

34698

Research Site, Dunedin

35406

Research Site, Tuscaloosa

35801

Research Site, Huntsville

37343

Research Site, Hixson

40217

Research Site, Louisville

45417

Research Site, Dayton

48910

Research Site, Lansing

58502

Research Site, Bismarck

66215

Research Site, Overland Park

68516

Research Site, Lincoln

71913

Research Site, Hot Springs

73103

Research Site, Oklahoma City

75231

Research Site, Dallas

78731

Research Site, Austin

80230

Research Site, Denver

85258

Research Site, Scottsdale

85304

Research Site, Glendale

92108

Research Site, San Diego

92780

Research Site, Tustin

94583

Research Site, San Ramon

93454-6945

Research Site, Santa Maria

V8V 3P9

Research Site, Victoria

A1C 5B8

Research Site, St. John's

L4M 7G1

Research Site, Barrie

L7R 1E2

Research Site, Burlington

L1E 3C3

Research Site, Courtice

L8N 1Y2

Research Site, Hamilton

L5M 2V8

Research Site, Mississauga

L6J 7W5

Research Site, Oakville

K9J 1Z2

Research Site, Peterborough

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY

NCT01875991 - Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept | Biotech Hunter | Biotech Hunter